Evaluation of a Modern System to Allow for Growth in Children With Scoliosis Versus a Conventional Treatment

NCT ID: NCT01672749

Last Updated: 2024-03-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

18 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-06-30

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The foremost challenge when managing early onset scoliosis (curve deformity before the age of 10) is to prevent curve progression while maintaining growth of the spine. Current treatment options require repetitive interventions as the spine and the child grow. This study will compare two techniques of growth modulation: Standard dual growing rods versus the new Luqué Trolley screws

Hypothesis: Patients treated with the DePuy Synthes TROLLEY system will undergo fewer re-operations after 3 years of follow-up (FU) than patients included in the comparison group

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this clinical study is to show that the growth guiding construct with DePuy Synthes TROLLEY Gliding Vehicles allows for less re-operations and for ongoing spinal growth across an instrumented immature spine while preventing curve progression in early onset scoliosis patients.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Early Onset Scoliosis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Spine based dual growing rod or VEPTR

Patients treated with the TROLLEY system will be compared with patients from the Chest Wall and Spine Deformity Study Group (CWSDSG) and the Growing Spine Study Group (GSSG) treated with a spine based dual growing rod or the rib based Vertical Expandable Prosthetic Titanium Rib (VEPTR, Synthes North America). For each patient in the TROLLEY group a patient from each of the databases will be selected to be matched based on diagnosis, age, gender, and spine deformity classification.

Spine based dual growing rod or rib based VEPTR

Intervention Type DEVICE

spine based dual growing rod or the rib based Vertical Expandable Prosthetic Titanium Rib (VEPTR, Synthes North America)

TROLLEY system

Growth guiding construct using the DePuy Synthes TROLLEY Gliding Vehicles (GVs). The TROLLEY system is CE marked at the time of the study conduct.

Growth guiding construct using TROLLEY system

Intervention Type DEVICE

Growth guiding construct using the DePuy Synthes TROLLEY Gliding Vehicles (GVs)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Growth guiding construct using TROLLEY system

Growth guiding construct using the DePuy Synthes TROLLEY Gliding Vehicles (GVs)

Intervention Type DEVICE

Spine based dual growing rod or rib based VEPTR

spine based dual growing rod or the rib based Vertical Expandable Prosthetic Titanium Rib (VEPTR, Synthes North America)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 5 - 10 years
* Diagnosis of Early Onset Scoliosis with any of the following etiologies:

Idiopathic Congenital Neuromuscular Syndromic Mesenchymal

\- Significant growth potential defined by any of the following: pre peek growth velocity bone age \< 10; open triradiate cartilage

* An expected significant spinal deformity of more than 80 degrees at skeletal maturity
* Signed informed consent as legally required (patient, parents, etc.)
* Willingness and ability of the patient to participate in the clinical investigation including imaging and FU procedures
* Willingness and ability of the parents to support the patient in his/her study participation
* Ability of the patient and parents to understand the content of the patient information / informed consent form and participate in the clinical investigation
* Signed informed consent by patient / parent(s)

Exclusion Criteria

* Curve magnitude and rigidity: Cobb greater than 100 degrees or bends less than 50 degrees
* Prior spinal surgery
* Skeletal maturity
* Any not medically managed severe systemic disease
* Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
Minimum Eligible Age

5 Years

Maximum Eligible Age

10 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

AO Innovation Translation Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jean Ouellet, MD

Role: PRINCIPAL_INVESTIGATOR

McGill University Health Science Centre, Montreal, Canada

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpitaux Universitaires de Genève

Geneva, , Switzerland

Site Status

Queen's Medical Centre

Nottingham, , United Kingdom

Site Status

Sheffield Children's Hospital

Sheffield, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Dayer R, Grevitt M, Breakwell L, Yoon W, Chen M, Ratz T, Szocik T, Zhu YY; Pediatric Spine Study Group (PSSG); Ouellet J. Management of early-onset scoliosis: modern Luque trolley technique led to fewer reoperations within 3 years than other growth-friendly techniques, a prospective cohort study with matched historical controls. Spine Deform. 2025 Sep;13(5):1611-1624. doi: 10.1007/s43390-025-01102-2. Epub 2025 May 28.

Reference Type DERIVED
PMID: 40437325 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EOS TROLLEY

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Trial on Three Treatments for Scoliosis
NCT01761305 ACTIVE_NOT_RECRUITING NA